Suara.com – Technological developments also facilitate early detection of a disease. One of which is prostate cancer, a disease that only causes symptoms when the stage is advanced.
Data from the Ministry of Health, prostate cancer ranks 4th with about 25,012 sufferers. Most patients are diagnosed at an advanced stage because early detection of prostate cancer is not optimal in Indonesia.
“In fact, prostate cancer patients diagnosed and treated at an early stage have a life expectancy of above 90 percent, up to 10 years. This figure can drop to 50 percent if found at an advanced stage, “said a specialist consultant uro-oncologist Siloam Hospitals ASRI dr. Agus Rizal Ardy Hariandy Hamid, Sp.U (K), PhD., In an online webinar, Wednesday (17 / 2/2021).
Utilizing technology, early detection of prostate cancer can now even be done with biopsy robotic. The early detection innovation was made by Siloam Hospitals center of excellence, ASRI Urology Center.
Also Read:
Sis Seto prostate cancer, these are 4 cancers that mostly attack men
Robotic prostate biopsy using a more precise target needle localization. However, Doctor Agus admitted, it is necessary to develop technology so that the available robotic devices can be used for daily clinical use.
According to him, a prostate biopsy with robotic technology has a shorter duration of action than a non-robotic biopsy.
“This is certainly beneficial for patients and medical personnel who are in the action room, especially during the Covid-19 pandemic. This technology can shorten the operation time so that contact between patients and medical personnel in the action room is minimal, “he explained.
Meanwhile, a urology specialist and Chair of the Asri Urology Center (AUC) Dr. dr. Nur Rasyid, Sp.U (K)., Also reminded the importance of early detection of prostate cancer to prevent potential complications and worsening health.
“Prostate biopsy with robotic technology is used to improve the accuracy of tissue sampling at prostate cancer cell sites. With this technology, the diagnosis will be faster and more accurate, the biopsy time will be shorter, and avoid re-biopsy, “he said.
Also Read:
Immunotherapy Can Be A Hope For Prostate Cancer Patients Like Ms. Seto
– .
